Jagsonpal Pharma soars after Q1 PAT climbs 22% YoY to Rs 13 cr
Mumbai, July 30 -- Revenue from operations grew 8.76% YoY to Rs 82.23 crore during the quarter from Rs 75.60 crore in Q1 FY26.
Profit before tax (PBT) climbed 22.52% YoY to Rs 17.68 crore in Q1 FY27.
Operating EBITDA rose 21.4% YoY to Rs 19.1 crore from Rs 15.7 crore in Q1 FY26. EBITDA margin expanded to 23.2% from 20.8% a year earlier, supported by operating leverage driven by improved medical representative (MR) productivity.
The company also highlighted the integration of Aequitas, which has a revenue base of Rs 53.3 crore. Management expects the acquisition to contribute to higher revenue and profitability from the second half of FY27 and is targeting EBITDA of more than Rs 10 crore by the second year after integration.
Manish Gup...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.